Stock Market Review 29AUG #shorts

Santhera’s Agamree becomes first approved treatment in UK for all DMD patients – Pharmaceutical Technology

Share this article Santhera’s chief medical officer Shabir Hasham said the company is planning on making Agamree available in the UK in the second half

January 12, 2024

Cervical Length Screening Did Not Reduce Rates of Preterm Births

NATIONAL HARBOR, Md. — Among pregnant women at low risk for preterm delivery, universal transvaginal ultrasound (TVU) cervical length screening did not reduce rates of

February 16, 2024

iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer – Biotech Investments

EQS-News: iOmx Therapeutics AG / Key word(s): Personnel iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer 05.09.2023 / 08:30 CET/CEST The issuer

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.